SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-23-165265
Filing Date
2023-06-12
Accepted
2023-06-12 16:01:50
Documents
3
Group Members
ACCESS INDUSTRIES HOLDINGS LLCACCESS INDUSTRIES MANAGEMENT, LLCACCESS INDUSTRIES, LLCCLAL INDUSTRIES LTD.LEN BLAVATNIK

Document Format Files

Seq Description Document Type Size
1 SC 13D d843907dsc13d.htm SC 13D 143055
2 EX-99.3 d843907dex993.htm EX-99.3 14900
3 EX-99.4 d843907dex994.htm EX-99.4 8018
  Complete submission text file 0001193125-23-165265.txt   167756
Mailing Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023
Business Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023 972-3-6075794
Clal Biotechnology Industries Ltd. (Filed by) CIK: 0001468950 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Subject) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93548 | Film No.: 231007986
SIC: 2834 Pharmaceutical Preparations